期刊文献+

奥曲肽对肝部分切除术后大鼠肝再生影响的实验研究 被引量:1

The influences of Octreotide on rat liver regeneration undergone partial hepatectomy
下载PDF
导出
摘要 目的 了解生长抑素 8肽类似物奥曲肽对肝部分切除术后大鼠肝脏再生和肝功能的影响 ,探讨奥曲肽手术后应用的安全性。方法 将 80只♂成年Wistar大鼠随机分为 5组 ,每组 16只。A、B组为单纯左肝切除组 ,其中B组腹腔注射奥曲肽 (5 0 μg/kg、Bid) ;C、D、E组均为左肝切除加右肝肿瘤种植组 ,D、E组分别在肿瘤种植后 12、72h开始同样方法剂量应用奥曲肽 ;A组为空白对照、C组作为荷瘤对照。结果 术后 1周A、B组间及C、D、E组间肝脏重量、增殖细胞核抗原 (PCNA)表达和DNA增殖以及术后肝功能等差异没有显著性 (P >0 0 5 )。结论 生长抑素类似物奥曲肽对部分切除后大鼠肝脏再生没有影响 ,并且与是否荷瘤无关。 Objective To assess the influences and security of Octreotide on rat liver regeneration and liver function undergone partial hepatectomy. Methods 80 male adult Wistar rats were divided into 5 groups, 16s in each group. Group A and B took only left lobe partial hepatectomy while Ocreotide (50 μg/kg)were administered intraperitoneally to group B twice a day. Walker-256 tumor was implanted in right lobe of liver of group C, D, E when their partial hepatectmoy of left lobe were operated. The first administered time for Octreotide on group D or E was 12 h and 72 h after resection respectively. Group A and C acted as blank and carrying control received a similar volume of saline. Results Each rat in weight of remnant liver, expression of PCNA, regenerative hepatic cell DNA content and liver function one week after resection were analyzed. There is no significant difference between A versus B or C, D versus E. Conclusion Octreotide has no significant suppression on hepatic cell regeneration without any relation with carrying tumor or not.
出处 《安徽医科大学学报》 CAS 2002年第1期38-40,共3页 Acta Universitatis Medicinalis Anhui
关键词 奥曲肽 药理学 肝切除术 肝再生 生长抑素 octreotide/pharmacology hepatectomy liver regeneration somatostatin liver neoplasms
  • 相关文献

参考文献3

  • 1杨继金,朱永法.大白鼠转移性肝癌模型的制作[J].中华放射学杂志,1993,27(2):122-123. 被引量:42
  • 2Kouroumalis E,Skordilis P, Thermos K et al. Treatment of hepatocellular carcinoma with octreotide:a randomized controlled study. Gut,1998;42(6):442~447
  • 3Reubi JC,Zimmermann A,Jonas S et al. Regulatory peptide receptors in human hepatocellular carcinomas. Gut,1999;45(6):766~774

二级参考文献2

  • 1钱振超,中华肿瘤杂志,1987年,9卷,187页
  • 2周金煦,中华肿瘤杂志,1986年,8卷,409页

共引文献41

同被引文献19

  • 1Foekens JA;Peters HA;Look MP.The urokinase system of plasminogen activation and prognosisin 2780 breast cancer patients,2000.
  • 2Suzuki N;Fujioka K;Denda-Nagai K.The macrophage C-type lectin specific for galactose/N-acety lgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells[J],2002(23).
  • 3Ogata R;Torimura T;Kin M.Increase depression of membrane type 1 oproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinoma (see comments),1999.
  • 4Saito K;Takeha S;Shibak.Clinicopathologic significance of urokinase receptor and MMPS-9-positive stromal cells in human colorectal cancer functional multiplicity of matrix degradation on hematogenous matatasis[J],2000(01).
  • 5Golderg RM;Moertel CG;Wieand HS.A phase evaluation of asomatostatin analogue(octreotide)in the treatment of patients with asymptomatic advanced colon carcinoma[J],1995(06).
  • 6Yuen MF;Poon RT;Lai CL.A randomized placebocontrolled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma[J],2002(03).
  • 7di Maio M;De Maio E;Perrone F.Hepatocellular carcinoma:systemic treatments[J],2002(Z2).
  • 8Dimitroulopoulos D;Xinopoulos D;Tsamakidis K.The role of sandcstatin LAR in treating patients with advanced hepatocellular cancer,2002(47).
  • 9Schindel DT.查看详情[J],1997(07).
  • 10Rabe C;Pilz T;Allgaier HP.Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide,2002(06).

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部